ANXA5 and prostate carcinoma: Thus, ectopically expressed OR51E1 and OR51E2 suppressed prostate cancer cells growth in association with the upregulation of cytostatic and cell death markers, including p27, p21 and p53, and enhanced annexin V staining [46].